EQS-Adhoc: REPLOID Group AG: REPLOID Group AG acquires stake in HEROSAN Healthcare GmbH – strategic focus on sustainable animal feed products and production.
EQS-Ad-hoc: REPLOID Group AG / Key word(s): Mergers &
Acquisitions/Alliance
REPLOID Group AG: REPLOID Group AG acquires stake in HEROSAN Healthcare
GmbH – strategic focus on sustainable animal feed products and production.
03-Oct-2025 / 12:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the
Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS
Group.
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Wels, 3 October 2025
REPLOID Group AG announces that it is acquiring a stake in HEROSAN
Healthcare GmbH, thereby expanding its involvement in the fast-growing
markets for sustainable animal feed products and production. The
acquisition of the company will take place in two phases. In 2025, REPLOID
Group AG will acquire more than 30% of the company’s shares, with a view
to increasing its stake to 100% in 2026 via a notarised ‘step-up option’.
HEROSAN pursues a clear, Europe-wide growth strategy focused on
sustainability, responsibility and healthy animal nutrition. With a wide
range of products from feed mixes with hemp and insect protein to
functional mushroom components and selected meat products, HEROSAN
positions itself as a supplier of a high-quality premium product range for
pets in specialist shops, food retailers and e-commerce.
With its entry into HEROSAN, REPLOID Group AG is strategically expanding
its investment portfolio to include a company with very strong growth
potential in a promising market segment. The aim of this investment and
cooperation is to position HEROSAN as one of Europe’s leading feed
producers in the coming years.
End of Inside Information
══════════════════════════════════════════════════════════════════════════
Information and Explanation of the Issuer to this announcement:
Important note
This announcement is a mandatory disclosure of inside information pursuant
to Article 17 of the Market Abuse Regulation (EU) No 596/2014. It does not
constitute financial analysis or advice or a recommendation relating to
financial instruments, nor does it constitute an offer, solicitation or
invitation to buy or sell securities of REPLOID Group AG.
Issuer REPLOID Group AG
Maria-Theresia-Straße 53/2 OG
4600 Wels
Austria
Contact Philip Pauer
CEO REPLOID Group AG
Tel. +43 660 4755556
Email investors@reploid.eu
Website: https://reploid.eu/
ISIN(s): AT0000A3HRX5 (share)
Stock exchange(s) Vienna Stock Exchange (Direct Market Plus)
══════════════════════════════════════════════════════════════════════════
03-Oct-2025 CET/CEST News transmitted by EQS Group. www.eqs.com
══════════════════════════════════════════════════════════════════════════
Language: English
Company: REPLOID Group AG
Maria-Theresia-Straße 53
4600 Wels
Austria
Phone: +43 660 / 776 50 40
E-mail: office@reploid.eu
Internet: reploid.eu
ISIN: AT0000A3HRX5
Listed: Vienna Stock Exchange (Vienna MTF)
EQS News ID: 2207210
IPO geplant, IPO planned;
End of Announcement EQS News Service
2207210 03-Oct-2025 CET/CEST
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2207210&application_name=news&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf
OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS. www.ots.at
© Copyright APA-OTS Originaltext-Service GmbH und der jeweilige Aussender